authors
- Zeiser, Robert
- Ram, Ron
- Foley, Ronan
- Yeshurun, Moshe
- Locatelli, Franco
- Gadbaw, Brian
- Atienza, Edric
- Hollaender, Norbert
- Teshima, Takanori
REACH-3 trial design: A Phase 3, Randomized Study to Assess Ruxolitinib over BAT in Patients with Corticosteroid-Refractory Chronic Graft-versus-Host Disease Post Allo-HSCT
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- September 1, 2018
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Immunology (Science Metrix)
published in
- Bone Marrow Transplantation Journal